TY - JOUR
T1 - Evidence that reduced gray matter volume in psychotic disorder is associated with exposure to environmental risk factors
AU - Frissen, Aleida
AU - van Os, Jim
AU - Peeters, Sanne
AU - Gronenschild, Ed
AU - Marcelis, Machteld
N1 - Funding Information:
This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Information:
This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [ G.R.O.U.P. ]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2017
PY - 2018/1/30
Y1 - 2018/1/30
N2 - The aim of this study was to examine whether cannabis use, childhood trauma and urban upbringing are associated with total gray matter volume (GMV) in individuals with (risk for) psychotic disorder and whether this is sex-specific. T1-weighted MRI scans were acquired from 89 patients with a psychotic disorder, 95 healthy siblings of patients with psychotic disorder and 87 controls. Multilevel random regression analyses were used to examine main effects and interactions between group, sex and environmental factors in models of GMV. The three-way interaction between group, sex and cannabis (χ2 =12.43, p<0.01), as well as developmental urbanicity (χ2 = 6.29, p = 0.01) were significant, indicating that cannabis use and developmental urbanicity were associated with lower GMV in the male patient group (cannabis: B= −32.54, p < 0.01; developmental urbanicity: B= −10.23, p=0.03). For childhood trauma, the two-way interaction with group was significant (χ2 = 5.74, p = 0.02), indicating that childhood trauma was associated with reduced GMV in the patient group (B=−9.79, p=0.01). The findings suggest that reduction of GMV in psychotic disorder may be the outcome of differential sensitivity to environmental risks, particularly in male patients.
AB - The aim of this study was to examine whether cannabis use, childhood trauma and urban upbringing are associated with total gray matter volume (GMV) in individuals with (risk for) psychotic disorder and whether this is sex-specific. T1-weighted MRI scans were acquired from 89 patients with a psychotic disorder, 95 healthy siblings of patients with psychotic disorder and 87 controls. Multilevel random regression analyses were used to examine main effects and interactions between group, sex and environmental factors in models of GMV. The three-way interaction between group, sex and cannabis (χ2 =12.43, p<0.01), as well as developmental urbanicity (χ2 = 6.29, p = 0.01) were significant, indicating that cannabis use and developmental urbanicity were associated with lower GMV in the male patient group (cannabis: B= −32.54, p < 0.01; developmental urbanicity: B= −10.23, p=0.03). For childhood trauma, the two-way interaction with group was significant (χ2 = 5.74, p = 0.02), indicating that childhood trauma was associated with reduced GMV in the patient group (B=−9.79, p=0.01). The findings suggest that reduction of GMV in psychotic disorder may be the outcome of differential sensitivity to environmental risks, particularly in male patients.
KW - Cannabis
KW - Childhood trauma
KW - Gene-environment interaction
KW - Gray matter
KW - Psychotic disorder
KW - Urbanization
UR - http://www.scopus.com/inward/record.url?scp=85034783150&partnerID=8YFLogxK
U2 - 10.1016/j.pscychresns.2017.11.004
DO - 10.1016/j.pscychresns.2017.11.004
M3 - Article
AN - SCOPUS:85034783150
SN - 0925-4927
VL - 271
SP - 100
EP - 110
JO - Psychiatry Research - Neuroimaging
JF - Psychiatry Research - Neuroimaging
ER -